Can Marsh Beat Q3 Earnings on Risk and Insurance Services Strength?
MRSH heads into Q3 earnings with forecasts for higher revenue and profit, supported by Risk and Insurance Services growth, while rising costs pose a challenge.
MRSH - Marsh & McLennan Companies, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$202.71
DETAILS
HIGH:
$234.00
LOW:
$182.00
MEDIAN:
$200.00
CONSENSUS:
$202.71
UPSIDE:
6.10%
Stock News
Marsh (MRSH) Earnings Expected to Grow: Should You Buy?
Marsh (MRSH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Wall Street Forecasters Revamp Marsh Expectations Ahead Of Q3 Earnings
Marsh & McLennan Companies, Inc. (NYSE:MRSH) will release its third quarter earnings report before the opening bell on Thursday, Oct. 15.
Marsh Completes Acquisition of Accel Holdings
Marsh (NYSE: MRSH), a leading global professional services firm, today announced the completion of its [url="]previously announced[/url] agreement to acquire Acc
Marsh Completes Acquisition of Accel Holdings
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE:MRSH), a leading global professional services firm, today announced the completion of its previously announced agreement to acquire Accel Holdings, Inc, a leading diversified independent insurance and advisory firm headquartered in Waverly, Iowa. Accel will operate within Marsh Agency. Terms of the acquisition were not disclosed. With the acquisition now closed, Marsh Agency's Upper Midwest team has strengthened its presence in Iowa and gained retirement a.
Marsh & McLennan Companies, Inc. (NYSE:MRSH) Stock Rated “Hold” by Sell-Side Analysts
Shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH - Get Free Report) have been assigned a consensus recommendation of "Hold" from the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation, five have issued a buy
Can Archer Help Marsh Tap Growth in Asset-Intensive Reinsurance?
MRSH's Archer service targets asset-intensive reinsurance, offering end-to-end support that could add recurring revenue and deepen client ties.
Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Honeywell International Inc. (NASDAQ: HON). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Honeywell International stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following
Crane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Crane (NYSE: CR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $50,001 and $100,000 in Crane stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s): Sold $15,001
Colgate-Palmolive (NYSE:CL) Stock Sale Revealed by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Colgate-Palmolive Company (NYSE: CL). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on August 27th. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made the following trade(s):
Walmart (NASDAQ:WMT) Shares Unloaded by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Walmart Inc. (NASDAQ: WMT). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in Walmart stock on August 27th. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made the following trade(s):
Novo Nordisk A/S (NYSE:NVO) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Novo Nordisk A/S (NYSE: NVO). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in Novo Nordisk A/S stock on August 31st. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made
Rep. Kevin Hern Sells Shares of Devon Energy Corporation (NYSE:DVN)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Devon Energy Corporation (NYSE: DVN). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Devon Energy stock on August 31st. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made the
Danaher (NYSE:DHR) Stock Unloaded by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Danaher Corporation (NYSE: DHR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Danaher stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s): Sold
Rep. Kevin Hern Sells Shares of ONEOK, Inc. (NYSE:OKE)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of ONEOK, Inc. (NYSE: OKE). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $50,001 and $100,000 in ONEOK stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s): Sold
Pembina Pipeline (NYSE:PBA) Stock Sold by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Pembina Pipeline Corp. (NYSE: PBA). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Pembina Pipeline stock on August 27th. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made the
Novartis (NYSE:NVS) Stock Sold by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Novartis AG (NYSE: NVS). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Novartis stock on August 27th. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account. Representative Kevin Hern also recently made the following trade(s):
Rep. Kevin Hern Purchases Shares of CocaCola Company (The) (NYSE:KO)
Representative Kevin Hern (Republican-Oklahoma) recently bought shares of CocaCola Company (The) (NYSE: KO). In a filing disclosed on September 25th, the Representative disclosed that they had bought between $1,001 and $15,000 in CocaCola stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s):
PTC (NASDAQ:PTC) Stock Sale Disclosed by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of PTC Inc. (NASDAQ: PTC). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $50,001 and $100,000 in PTC stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following trade(s): Sold
Progress Software (NASDAQ:PRGS) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Progress Software Corporation (NASDAQ: PRGS). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Progress Software stock on August 31st. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account. Representative Kevin Hern also recently made the following
Price Targets
Marsh McLennan price target lowered to $190 from $201 at Mizuho
$190.00
(was $171.75)
Mizuho Securities
Marsh McLennan price target raised to $222 from $216 at UBS
$222.00
(was $170.43)
UBS
Marsh McLennan price target raised to $203 from $189 at BMO Capital
$203.00
(was $194.67)
BMO Capital
Marsh McLennan price target raised to $200 from $180 at Morgan Stanley
$200.00
(was $186.37)
Morgan Stanley
Marsh McLennan price target raised to $216 from $212 at UBS
$216.00
(was $184.62)
UBS
Marsh (MRSH) PT Raised to $201 at Mizuho
$201.00
(was $181.59)
Yaron Kinar
·
Mizuho Securities
Marsh McLennan price target raised to $188 from $186 at Wells Fargo
$188.00
(was $181.59)
Wells Fargo
Marsh McLennan price target raised to $180 from $175 at Morgan Stanley
$180.00
(was $182.22)
Morgan Stanley
Marsh McLennan price target lowered to $234 from $236 at Evercore ISI
$234.00
(was $179.91)
Evercore ISI
Marsh McLennan price target raised to $197 from $194 at Mizuho
$197.00
(was $179.05)
Mizuho Securities
Marsh McLennan price target raised to $212 from $203 at UBS
$212.00
(was $177.18)
UBS
Marsh McLennan price target lowered to $175 from $180 at Morgan Stanley
$175.00
(was $178.54)
Morgan Stanley
Marsh McLennan price target lowered to $203 from $230 at UBS
$203.00
(was $162.52)
Brian Meredith
·
UBS
Marsh McLennan price target lowered to $182 from $190 at Piper Sandler
$182.00
(was $164.11)
Piper Sandler
Marsh McLennan price target lowered to $180 from $190 at Morgan Stanley
$180.00
(was $163.38)
UBS
Marsh McLennan price target lowered to $193 from $199 at Mizuho
$193.00
(was $171.93)
Mizuho Securities
Marsh McLennan upgraded to Strong Buy from Outperform at Raymond James
$225.00
(was $174.06)
Strong Buy
·
Raymond James
Marsh McLennan price target raised to $212 from $208 at Cantor Fitzgerald
$212.00
(was $190.46)
Cantor Fitzgerald
Marsh McLennan price target raised to $213 from $212 at Mizuho
$213.00
(was $188.19)
Mizuho Securities
Marsh McLennan price target lowered to $208 from $226 at Cantor Fitzgerald
$208.00
(was $182.70)
Cantor Fitzgerald